NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer. These proteins are implicated in epidermal squamous cell carcinoma in mice, however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours, blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma. Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer, it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon cotransfection with the human TERT gene, defined sets of oncogenes, specifically activated H-RAS, SV40 large T antigen and SV40 small t antigen, resulted in the efficient malignant transformation of human fibroblasts (96).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [96]
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Cutaneous Squamous-Cell Carcinoma
Alam, M., & Ratner, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441306 · Cited by 1,305
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098 · cited 1×
“jpg" NDATA ITEM> ]> The nuclear factor NF-κB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cance”
BackgroundHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 1×
“Ectopic subcutaneous tumour formation in mice often requires administration of matrigel or fibroblast-derived matri”
BackgroundBlocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831 · cited 1×
“Because therapeutics inhibiting Ras and NF-κB pathways are being developed to treat human cance”
Background
Cited by
Items 301–400 of 540
Imiquimod Induces Apoptosis of Squamous Cell Carcinoma (SCC) Cells via Regulation of A20
Sohn, K., Li, Z. J., Choi, D.-K., Zhang, T., Lim, J. W., Chang, I.-K., Hur, G. M., Im, M., Lee, Y., Seo, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095337 · Cited by 39
Yang, S.-T., Yen, C.-J., Lai, C.-H., Lin, Y., Chang, K., Lee, J., Liu, Y.-W., Chang‐Liao, P., Hsu, L.-S., Chang, W., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.025 · Cited by 35
“However, previous reports indicated that inhibition of NF-jB promotes carcinogenesis [9,10].”
BackgroundXiang, N., He, M., Ishaq, M., Gao, Y., Song, F., Guo, L., Ma, L., Sun, G., Liu, D., Guo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164471 · Cited by 35
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor
Voce, D. J., Schmitt, A. M., Uppal, A., McNerney, M. E., Bernal, G. M., Cahill, K. E., Wahlstrom, J. S., Nassiri, A., Yu, X., Crawley, C. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.211 · Cited by 35
Molecular diagnosis in dermatopathology: What makes sense, and what doesn’t
Braun‐Falco, M., Schempp, W., & Weyers, W. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00805.x · Cited by 36
Carucci, J. A. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2004.23440.x · Cited by 34
The role of barrier genes in epidermal malignancy
Darido, C., Georgy, S. R., & Jane, S. M. (2016) · Oncogene · doi:10.1038/onc.2016.84 · Cited by 38
Review: NF-kB activation in canine cancer
Schlein, L. J., & Thamm, D. H. (2022) · Veterinary Pathology · doi:10.1177/03009858221092017 · Cited by 37
Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis
Kern, F., Doma, E., Rupp, C., Niault, T., & Baccarini, M. (2012) · Oncogene · doi:10.1038/onc.2012.254 · Cited by 32
Xiao, X., Yang, G. S., Bai, P., Gui, S., Nguyen, T. M. B., Mercado‐Uribe, I., Yang, M., Zou, J., Li, Q., Xiao, J., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2617-2 · Cited by 33
“A novel role for NF-kB has been suggested in several recent studies, specifically, involvement of NFkB in tumor suppress has been demonstrated in skin and liver [35–37].”
BackgroundLoss of Ikkβ Promotes Migration and Proliferation of Mouse Embryo Fibroblast Cells
Chen, F., Lu, Y., Castranova, V., Li, Z., & Karin, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603631200 · Cited by 39
The TRAF-Interacting Protein (TRIP) Is a Regulator of Keratinocyte Proliferation
Almeida, S. M., Ryser, S., Obarzanek-Fojt, M., Hohl, D., & Huber, M. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.329 · Cited by 35
“, 2003), growth inhibition by TRIP shRNA could be because of NF-kB activation triggering cell cycle arrest in epithelial cells (Kaufman and Fuchs, 2000; Seitz et al., 2000; Dajee et al., 2003).”
BackgroundZhang, X., Jin, J. Y., WU, J. M., Qin, X., Streilein, R. D., Hall, R. P., & Zhang, J. Y. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.519 · Cited by 32
“On the other hand, persistent NF-κB activation promotes epidermal aging and inhibits cutaneous neoplasia (Adler et al., 2007; Dajee et al., 2003; Zhang et al., 2004; Zhang et al., 2005b).”
BackgroundSelf-citationmiRNA–mRNA crosstalk in esophageal cancer: From diagnosis to therapy
Sharma, P., & Sharma, R. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.07.002 · Cited by 32
Loss of Nuclear Factor-κB Is Tumor Promoting but Does Not Substitute for Loss of p53
Ryan, K. M., O’Prey, J., & Vousden, K. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1474 · Cited by 31
“This apparent contradiction to the well-established antiapoptotic role of NF-B was not without precedent, however, as NF-B has also been reported to contribute to death induced by Fas or after infection with certain viruses (8, 9). In line with these conflicting roles in the regulation of apoptosis are a number of opp…”
BackgroundA Role for NF-κB Activity in Skin Hyperplasia and the Development of Keratoacanthomata in Mice
Poligone, B., Hayden, M. S., Chen, L., Pentland, A. P., Jimi, E., & Ghosh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071887 · Cited by 33
“In contrast to the accepted view of NF-κB as supporting carcinogenesis, tumor proliferation and survival, a murine model in which NF-κB activity is constitutively inhibited through the expression of the IκBα super-repressor (K5IκBαSR) demonstrates spontaneous SCC development [6].”
InfluentialChen, Y.-Y., Chiang, S., Wu, H.-C., Kao, S.-T., Hsiang, C., Ho, T., & Lin, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.197 · Cited by 30
Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation
Watt, S. A., Purdie, K. J., den Breems, N. Y., Dimon, M. T., Arron, S. T., McHugh, A. T., Xue, D. J., Dayal, J. H. S., Proby, C. M., Harwood, C. A., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.05.018 · Cited by 33
Cutaneous Leukemia Inhibitory Factor and Its Potential Role in the Development of Skin Tumors
McKenzie, R. C., & Szepietowski, J. C. (2004) · Dermatologic Surgery · doi:10.1097/00042728-200402002-00009 · Cited by 34
Faurschou, A., Gniadecki, R., Calay, D., & Wulf, H. C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.19 · Cited by 29
“Whereas in normal keratinocytes NF-kB signaling seem to protect against squamous cell carcinoma, deregulated NF-kB activity in initiated tumor cells confers the antiapoptotic, mitogenic signal (Dajee et al., 2003; Loercher et al., 2004).”
BackgroundRelB inhibits cell proliferation and tumor growth through p53 transcriptional activation
Jacque, É., Billot, K., Authier, H., Bordereaux, D., & Baud, V. (2012) · Oncogene · doi:10.1038/onc.2012.282 · Cited by 34
Myc, Aurora Kinase A, and mutant p53R172H co-operate in a mouse model of metastatic skin carcinoma
Torchia, E. C., Caulín, C., Acín, S., Terzian, T., Kubick, B. J., Box, N. F., & Roop, D. R. (2011) · Oncogene · doi:10.1038/onc.2011.441 · Cited by 29
“In the absence of activating RAS mutations, elevated levels of active, GTP-bound RAS have been reported in a high number of SCCs (Dajee et al., 2003), as well as the overexpression of RAS family members (Paterson et al., 1996; Lu et al., 2006).”
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
Masoumi, K. C., Shaw-Hallgren, G., & Massoumi, R. (2011) · Journal of Skin Cancer · doi:10.1155/2011/614097 · Cited by 30
“These studies could show spon-taneous development of malignant SCC in transgenic mice expressing I κ B α M or the production of large neoplasms and SCC in human skin tissues by coexpression of I κ B α M and Ras [18, 19].”
Feng, G., Zhang, M., Wang, H., Cai, J., Chen, S., Wang, Q., Gong, J., Leong, K. W., Wang, J., Zhang, X., et al. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900018 · Cited by 28
Order of genetic events is critical determinant of aberrations in chromosome count and structure
Fauth, C., O’Hare, M. J., Lederer, G., Jat, P., & Speicher, M. R. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20051 · Cited by 30
“In addition, malignant transformation of human epidermal and fibroblastic cells in the absence of hTERT and LT transduction has been demonstrated, and 24-color karyotyping analysis of the tumors revealed a normal diploid chromosome complement (Lazarov et al., 2002; Dajee et al., 2003).”
BackgroundMice Lacking the p53/p63 Target Gene Perp Are Resistant to Papilloma Development
Marques, M. R., Horner, J. S., Ihrie, R. A., Bronson, R. T., & Attardi, L. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0366 · Cited by 28
“Similarly, expression of a6h4-integrin and its ligand laminin 5 have been shown to be critical for squamous cell tumorigenesis ( 32 ).”
BackgroundNuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer
Jones, R. L., Rojo, F., A’Hern, R., Villena, N., Salter, J., Corominas, J. M., Servitja, S., Smith, I. E., Rovira, A., Reis-Filho, J. S., et al. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.082966 · Cited by 28
“There is burgeoning evidence to support a putative tumour suppressor role for NF-κB/p65 in particular in certain cellular contexts and when some stimuli are involved. A number of studies have demonstrated that inhibition of NF-κB in skin cells leads to disturbed epidermal homoeostasis and the development of spontaneou…”
BackgroundGuan, Y., Yang, Y. J., Nagarajan, P., & Ge, Y. (2020) · Experimental Dermatology · doi:10.1111/exd.14247 · Cited by 28
Pathways Sufficient to Induce Epidermal Carcinogenesis
Ridky, T. W., & Khavari, P. A. (2004) · Cell Cycle · doi:10.4161/cc.3.5.860 · Cited by 28
Self-citationRapp, U. R., Rennefahrt, U. E. E., & Troppmair, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.015 · Cited by 33
Hemidesmosomes: Molecular Organization and Their Importance for Cell Adhesion and Disease
Köster, J., Borradori, L., & Sonnenberg, A. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68170-0_9 · Cited by 27
Singh, K., Sinha, S., Malonia, S. K., Bist, P., Tergaonkar, V., & Chattopadhyay, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801088200 · Cited by 26
Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation
DeRouen, M. C., Zhen, H., Tan, S. H., Williams, S., Marinkovich, M. P., & Oro, A. E. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-112 · Cited by 26
“In human graft models of SCC, epithelial downgrowth depends on both Itb1 and LM332, which indicates a need for both adheshion and signaling for continued epithelial growth [24].”
BackgroundSelf-citationPreciado, D. A., Caicedo, E., Jhanjee, R., Silver, R., Harris, G. F., Juhn, S. K., Choo, D. I., & Ondrey, F. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2964 · Cited by 28
Non-conventional functions for NF-κB members: the dark side of NF-κB
Espinosa, L., Margalef, P., & Bigas, A. (2014) · Oncogene · doi:10.1038/onc.2014.188 · Cited by 28
Pascua, P., Camello‐Almaraz, C., Camello, P. J., Martín‐Cano, F. E., Vara, E., Fernández-Tresguerres, J. Á., & Pozo, M. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00904.x · Cited by 25
Cell Motility in Cancer Invasion and Metastasis
Qin, Z., Tan, S. X. D., & Cheng, C.-K. (2006) · Cancer metastasis · doi:10.1007/b103440 · Cited by 27
RalA suppresses early stages of Ras-induced squamous cell carcinoma progression
Sowalsky, A. G., Alt-Holland, A., Shamis, Y., Garlick, J. A., & Feig, L. A. (2010) · Oncogene · doi:10.1038/onc.2009.307 · Cited by 25
“A significant proportion of these cancers contain either mutations in Ras genes that lead to constitutively-activated Ras GTPases or amplified levels of Ras proteins (Dajee et al., 2003; Pierceall et al., 1991).”
BackgroundMek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin
Scholl, F. A., Dumesic, P. A., Barragan, D. I., Charron, J., & Khavari, P. A. (2009) · Oncogene · doi:10.1038/onc.2008.459 · Cited by 25
Self-citationYaagoubi, O. M. E., Oularbi, L., Bouyahya, A., Samaki, H., Antri, S. E., & Aboudkhil, S. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1978785 · Cited by 24
Chen, L., Li, M., Zhou, H., Liu, Y., Pang, W. Y., Ma, T., Niu, C., Yang, Z., Chang, A. K., Li, X., et al. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02989-7 · Cited by 23
Toufighi, K., Yang, J., Luis, N. M., Benitah, S. A., Lehner, B., Serrano, L. G., & Kiel, C. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004256 · Cited by 23
NF-κB signaling and crosstalk during carcinogenesis
Brücher, B. L. D. M., Lang, F. J. W., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2019010 · Cited by 34
Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases
Fang, M., Wee, S. A., Ronski, K., Fan, H., Tao, S., & Lin, Q. (2007) · Genomic Medicine · doi:10.1007/s11568-007-9010-9 · Cited by 23
“consistent with its elucidated biological function in invasive carcinomas (Dajee et al. 2003; Mercurio 2003).”
BackgroundSelf-citationSenescence as a modulator of oral squamous cell carcinoma development
Parkinson, E. K. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.009 · Cited by 26
Regulation of NF-κB by atypical activators and tumour suppressors
Perkins, N. D. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320936 · Cited by 23
Szaefer, H., Cichocki, M., Krajka‐Kuźniak, V., Stefański, T., Sobiak, S., Licznerska, B. E., & Baer‐Dubowska, W. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.012 · Cited by 22
Patel, G. K., Yee, C., Yuspa, S. H., & Vogel, J. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.284 · Cited by 22
Chung, H. J., & Mahalingam, M. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.883281 · Cited by 25
Review Paper: The Role of Inflammation in Mouse Pulmonary Neoplasia
Bauer, A. K., & Rondini, E. A. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0217-b-rev · Cited by 22
FLIP ing the coin? Death receptor‐mediated signals during skin tumorigenesis
Leverkus, M., Diessenbacher, P., & Geserick, P. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00728.x · Cited by 24
Expression of CYLD and NF- κ B in Human Cholesteatoma Epithelium
Byun, J. Y., Yune, T. Y., Lee, J. Y., Yeo, S. G., & Park, M. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/796315 · Cited by 21
“The role of NF-κB in epithelial keratinocytes has been described as being paradoxical in other cell types such as T cells and B cells [13].”
BackgroundSalo, S., Boutaud, A., Hansen, A. J., He, L., Sun, Y., Morales, S., Venturini, A., Martin, P., Nokelainen, P., Betsholtz, C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24532 · Cited by 21
Doma, E., Rupp, C., Varga, A., Kern, F., Riegler, B., & Baccarini, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0748 · Cited by 21
Cai, H., Sun, L., Li, C., Cao, Q., Qin, C., Zhang, G., Mao, X., Wang, M., Zhang, Z., Shao, P., et al. (2012) · Urologia Internationalis · doi:10.1159/000345630 · Cited by 21
Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma
Santana, A. L., Felsen, D., & Carucci, J. A. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2016.07.003 · Cited by 21
Loss of the HPV-Infection Resistance EVER2 Protein Impairs NF-κB Signaling Pathways in Keratinocytes
Vuillier, F., Gaud, G., Guillemot, D., Commère, P., Pons, C., & Fãvre, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089479 · Cited by 21
Mahale, A. M., Khan, Z., Igarashi, M., Nanjangud, G. J., Qiao, R., Yao, S., Lee, S. W., & Aaronson, S. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3021 · Cited by 22
Downward, J. (2009) · Nature · doi:10.1038/462044a · Cited by 21
NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancer
Koerner, L., Schmiel, M., Yang, T.-P., Peifer, M., Buettner, R., & Pasparakis, M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01112-5 · Cited by 22
Controlling Hair Follicle Signaling Pathways through Polyubiquitination
Huntzicker, E. G., & Oro, A. E. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700957 · Cited by 28
“Conversely, overexpression of non-destructable IκB results in NF-κB inactivation, subsequent hyperplasia, and sensitivity to Ras-induced neoplasia (Dajee et al., 2003).”
BackgroundGene expression changes in uterine myomas in response to ulipristal acetate treatment
Courtoy, G. E., Donnez, J., Ambroise, J., Arriagada, P., Luyckx, M., Marbaix, É., & Dolmans, M. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.04.050 · Cited by 21
Molecular Biology of Basal and Squamous Cell Carcinomas
Boeckmann, L., Martens, M. C., & Emmert, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_9 · Cited by 21
PKK Suppresses Tumor Growth and Is Decreased in Squamous Cell Carcinoma of the Skin
Poligone, B., Gilmore, E. S., Alexander, C. V., Oleksyn, D. W., Gillespie, K., Zhao, J., Ibrahim, S. F., Pentland, A. P., Brown, M. D., & Chen, L. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.428 · Cited by 20
Das, C. R., Tiwari, D., Dongre, A., Khan, M. A., Husain, S. A., Sarma, A., Bose, S., & Bose, P. D. (2018) · Viral Immunology · doi:10.1089/vim.2017.0151 · Cited by 21
HSD17B7 gene in self‐renewal and oncogenicity of keratinocytes from Black versus White populations
Xu, X., Tassone, B., Ostano, P., Katarkar, A., Proust, T., Joseph, J., Riganti, C., Chiorino, G., Kutalik, Z., Lefort, K., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114133 · Cited by 21
“They were then superin-fected with an oncogenic H-ras V12 expressing retrovirus (LZRS-H-ras V12 ; (Dajee et al , 2003)) for 24 h prior to in vivo testing.”
Rapraeger, A. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.775349 · Cited by 20
Non-melanoma skin cancer: pathogenesis and mechanisms
Lauth, M., Undén, A. B., & Toftgård, R. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.005 · Cited by 20
DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue
Gazzi, T., Lesina, M., Wang, Q., Berninger, A., Radetzki, S., Demir, İ. E., Kohlmann, L., Meiser, W., Wilke, S., von Kries, J. P., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318485 · Cited by 18
Tumor Protein p63/Nuclear Factor κB Feedback Loop in Regulation of Cell Death
Sen, T., Sen, N., Huang, Y., Sinha, D., Luo, Z., Ratovitski, E. A., & Sidransky, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257105 · Cited by 21
Zhang, L., Wang, W., Jin, J. Y., Degan, S., Zhang, G., Erdmann, D., Hall, R. P., & Zhang, J. Y. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2918 · Cited by 18
“Additionally, this technique has provided a valuable experimental platform for gene function and mechanistic studies for oncogenes and tumor suppressors (Dajee et al., 2003; Jin et al., 2011; Ratushny et al., 2012).”
MethodSelf-citationInvasive skin carcinoma—Ras and α6β4 integrin lead the way
Mercurio, A. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00049-7 · Cited by 18
Targeting NF-κB in Anticancer Adjunctive Chemotherapy
Haefner, B. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_10 · Cited by 18
Törgyekes, E., Shanske, A. L., Anyane‐Yeboa, K., Nahum, O., Pirzadeh-Miller, S. M., Blumfield, E., Jobanputra, V., Warburton, D., & Levy, B. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34090 · Cited by 18
Maurelli, R., Tinaburri, L., Gangi, F. M., Bondanza, S., Severi, A. L., Scarponi, C., Albanesi, C., Mesiti, G., Guerra, L., Capogrossi, M. C., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.176842 · Cited by 18
“Thus, expression of Ras in primary cells does not promote transformation unless accompanied by cooperating oncogenes or coincident loss of functional p53 or pRb pathways (Dajee et al., 2003; Lazarov et al., 2002).”
BackgroundMEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma
Adelmann, C. H., Truong, K. A., Liang, R. J., Bansal, V. V., Gandee, L., Saporito, R. C., Lee, W., Du, L., Nicholas, C., Napoli, M., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.110 · Cited by 18
“Elevated phosphoMEK/ERK is also seen in sporadic human cuSCC (Dajee et al., 2003; Einspahr et al., 2012).”
Cell death as an architect of adult skin stem cell niches
Lecomte, K., Toniolo, A., & Hoste, E. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01297-3 · Cited by 17
Lotti, R., Palazzo, E., Petrachi, T., Dallaglio, K., Saltari, A., Truzzi, F., Quadri, M., Puviani, M., Maiorana, A., Marconi, A., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010089 · Cited by 16
“The coexpression of RasG12V and IκBα (RasG12V-IκBαM) in human keratinocytes used to regenerate skin in immuno-deficient mice promote the formation of rapidly growing tumors resembling SCC [9].”
BackgroundInhibition of NF-κB signaling via tyrosine phosphorylation of Ymer
Kameda, H., Watanabe, M., Bohgaki, M., Tsukiyama, T., & Hatakeyama, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.102 · Cited by 15
Ryan, W. K., Fernandez, J., Peterson, M. K., Sheneman, D. W., Podell, B. K., De, S., & Torchia, E. C. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0167-7 · Cited by 16
Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
Moussawi, K. A., Chung, K., Carroll, T. M., Osterburg, C., Smirnov, A., Lotz, R., Miller, P. F., Dedeić, Z., Zhong, S., Oti, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111503 · Cited by 16
Risk of skin cancer in multiple myeloma patients: a retrospective cohort study
Robinson, A. A., Wang, J., Vardanyan, S., Madden, E., Hebroni, F., Udd, K. A., Spektor, T. M., Nosrati, J. D., Kitto, A., Zahab, M., et al. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12748 · Cited by 15
In vitro experimental models of mesothelioma revisited
Singh, A. N., Pruett, N. D., & Hoang, C. D. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.04.12 · Cited by 15
Cultivation and Retroviral Infection of Human Epidermal Keratinocytes
Watt, F. M., Simon, B. M., & Prowse, D. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012164730-8/50017-4 · Cited by 15
Partners in death: a role for p73 and NF-kB in promoting apoptosis
Vousden, K. H. (2009) · Aging · doi:10.18632/aging.100033 · Cited by 15
NF-κB involvement in tumor–stroma interaction of squamous cell carcinoma
Ikebe, T., Nakayama, H., Shinohara, M., & Shirasuna, K. (2004) · Oral Oncology · doi:10.1016/j.oraloncology.2004.05.007 · Cited by 15
Zhou, J. P., Zhang, Y., Han, Z., Dong, Z., Cao, T., Wei, A., Guo, P., & Meng, Q. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1568747 · Cited by 14
“For abnormal CSCC tumor, it was reported that the NF-κB signal pathway could either enhance [22,23] or inhibit [24,25] apoptosis of CSCC in many different model systems.”
BackgroundRetractedDuran, C. L., Karagiannis, G. S., Chen, X., Sharma, V. P., Entenberg, D. R., Condeelis, J. S., & Oktay, M. H. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01628-1 · Cited by 14
Zhao, H., Li, S., Luo, F., TAN, Q., Li, H., & Zhou, W. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2116 · Cited by 14
Sun, Y., Ren, Y., Zhang, Y., Han, Y., Yang, Y., Gao, Y., Zhu, L.-L., Qi, R., Chen, H., & Gao, X. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.05.006 · Cited by 14
Double-sided niche regulation in skin stem cell and cancer: mechanisms and clinical applications
Pham, Q. T. T., Kuo, Y., Chang, W., Weng, H.-J., & Huang, Y.-H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02289-8 · Cited by 13
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
Thai, A. A., Lim, A. M. L., Solomon, B., & Rischin, D. (2021) · Cancers · doi:10.3390/cancers13225645 · Cited by 15
Kaur, S., Kizoulis, M. G., Fantasia, J., Oddos, T., Bigot, N., Galéra, P., Tucker‐Samaras, S., Leyden, J. J., & Southall, M. D. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13747 · Cited by 13
ErbB2 Makes β4 Integrin an Accomplice in Tumorigenesis
Muthuswamy, S. K. (2006) · Cell · doi:10.1016/j.cell.2006.07.020 · Cited by 14
“444 Cell 126, August 11, 2006 ©2006 Els For instance, in a model of human epidermal neoplasia induced by Ras-NF-κB, primary human keratinocytes from patients with mutations in β4 integrin fail to form tumors when transplanted into nude mice (Dajee et al., 2003).”
BackgroundStathopoulos, G. T., Sherrill, T. P., Han, W., Sadikot, R. T., Polosukhin, V. V., Fingleton, B., Yull, F. E., & Blackwell, T. S. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9100-z · Cited by 13
Tumour–host interactions: implications for developing anti-cancer therapies
Gadea, B. B., & Joyce, J. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000172 · Cited by 15
Re-evaluating PARP1 inhibitor in cancer
Tulin, A. V. (2011) · Nature Biotechnology · doi:10.1038/nbt.2058 · Cited by 13
Lehnerdt, G. F., Bánkfalvi, Á., Grehl, S., Adamzik, M., Lang, S., Schmid, K. W., Siffert, W., & Riemann, K. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100407 · Cited by 12
PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis
Chen, L., Hayden, M. S., Gilmore, E. S., Alexander‐Savino, C. V., Oleksyn, D. W., Gillespie, K., Zhao, J., & Poligone, B. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx120 · Cited by 13
t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65
Li, J., Liu, H., Xing, B., Yu, Y., Wang, H., Chen, G., Gu, B., Zhang, G., Wei, D., Gu, P., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0841-4 · Cited by 12
Metadata
- Authors
- Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., & Khavari, P. A.
- Affiliations
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- ORCID
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6923
- Pages
- 639-643
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986301169
- Cited by
- 535
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 20 · 2015: 21 · 2014: 22 · 2013: 25 · 2012: 23
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, oncogenic Ras, IκBα, cell cycle arrest, laminin-5, alpha6beta4 integrin, carcinogenesis, skin cancer
- MeSH terms
- NF-KappaB Inhibitor alpha, Kalinin, Animals, Cell Division, Epidermis, Humans, Mice, Nude, Neoplasm Invasiveness, Neoplasms, Genes, ras, Transduction, Genetic, Keratinocytes, Oncogene Protein p21(ras), Cell Adhesion Molecules, NF-kappa B, Mice, SCID, Telomere, Apoptosis, Cyclin-Dependent Kinases, I-kappa B Proteins, Integrin alpha6beta4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.